Synlogic, Inc. SEC filings SYBX
Synlogic, Inc. has 627 filings in SEC EDGAR's recent list, going back to Aug 23, 2011. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 29, 2026 (material agreement, change to shareholder rights, change in control, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3/A | Filing | Aug 15, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| 424B4 | Prospectus | Oct 2, 2023 | — |
| S-1MEF | Filing | Sep 28, 2023 | — |
| S-1/A | Amended registration statement | Sep 28, 2023 | — |
| S-1/A | Amended registration statement | Sep 27, 2023 | — |
| S-1 | Registration statement | Sep 8, 2023 | — |
| 424B5 | Prospectus supplement | Apr 4, 2023 | — |
| S-8 | Employee stock plan registration | Mar 29, 2023 | — |
| S-8 | Employee stock plan registration | Mar 29, 2023 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 424B5 | Prospectus supplement | Sep 23, 2021 | — |
| 424B5 | Prospectus supplement | Sep 22, 2021 | — |
| S-3 | Shelf registration | Jul 23, 2021 | — |
| 424B5 | Prospectus supplement | Apr 19, 2021 | — |
| 424B5 | Prospectus supplement | Apr 15, 2021 | — |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| 424B5 | Prospectus supplement | Feb 10, 2021 | — |
| 424B5 | Prospectus supplement | Mar 18, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| 424B3 | Prospectus | Sep 17, 2019 | — |
| S-3/A | Filing | Aug 30, 2019 | — |
| S-3 | Shelf registration | Aug 8, 2019 | — |
| S-8 | Employee stock plan registration | Mar 12, 2019 | — |
| S-3/A | Filing | Aug 23, 2018 | — |
| S-3 | Shelf registration | Aug 9, 2018 | — |
| 424B5 | Prospectus supplement | Apr 6, 2018 | — |
| S-8 | Employee stock plan registration | Mar 20, 2018 | — |
| 424B5 | Prospectus supplement | Jan 25, 2018 | — |
| 424B5 | Prospectus supplement | Jan 23, 2018 | — |
| S-3 | Shelf registration | Oct 13, 2017 | — |
| S-8 | Employee stock plan registration | Oct 5, 2017 | — |
| 424B3 | Prospectus | Jul 13, 2017 | — |
| S-4/A | Amendment no. 1 to form s-4 | Jul 11, 2017 | — |
| S-4 | Registration for a merger or exchange | Jun 21, 2017 | — |
| S-8 | Employee stock plan registration | Mar 30, 2016 | — |
| S-8 | Employee stock plan registration | Oct 6, 2015 | — |
| 424B4 | Prospectus | Oct 1, 2015 | — |
| FWP | Free writing prospectus | Sep 30, 2015 | — |
| S-1/A | Amended registration statement | Sep 30, 2015 | — |
| S-1/A | Amended registration statement | Sep 29, 2015 | — |
| S-1/A | Amended registration statement | Sep 25, 2015 | — |
| S-1/A | Amended registration statement | Sep 18, 2015 | — |
| S-1/A | Amended registration statement | Sep 11, 2015 | — |
| S-1 | Registration statement | Aug 24, 2015 | — |
Showing 50 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SYBX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Winchester, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1527599
- Former names
- Mirna Therapeutics, Inc. (until Aug 25, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.